MILAN & MORRISTOWN, N.J., June 25, 2024--Newron reports data from its 2024 Investor Day indicating evenamide would be uniquely effective in patients with treatment resistant schizophrenia
MILAN & MORRISTOWN, N.J., June 18, 2024--Newron Pharmaceuticals to host its 2024 Investor Day on June 25, 2024, in New York City. Live webcast beginning at 9:00 AM EDT.
MILAN & MORRISTOWN, N.J., June 05, 2024--Newron Pharmaceuticals will host its 2024 Investor Day on June 25 in New York City. New hope emerges for treatment-resistant schizophrenia.